End the duopoly

Working For The Enemy: Biotech Hires Black Social Justice Advocate To Lobby For Profitable Pricing For COVID-19 Drugs

Working for the enemy: the 1,000-member Biotechnology Innovation Organization trade group has hired a Black social justice advocate to lobby for profitable pricing for covid-19 drugs.

The world’s largest science and public advocacy organization, Biotechnology Innovation Organization (BIO), has a new chief lobbyist.

Social justice advocate, physician and molecular immunologist Michelle McMurry-Heath is the organization’s new president and CEO, succeeding former Republican congressman Rep. Jim Greenwood, who led the organization since 2005.

She’ll be heading up the world’s largest biotech trade association, whose members include companies that make pharmaceutical drugs, biofuels, industrial enzymes, and genetically modified crops.

Related Posts
1 of 347

At age 50, McMurry-Heath is as different from her predecessor as one could imagine, STAT reported. She’s “a veteran of Democratic presidential campaigns, a former official at the Food and Drug Administration, and the first Black person to graduate with an M.D.-Ph.d. from Duke University.”

She is also the first woman and African American to lead BIO, a 1,000-member organization that lobbies on behalf of companies providing services or products to biotechnology companies including drug, diagnostics, and agriculture industries.

Members pay flat fees annually for BIO’s services based on their number of employees, ranging from $3,500 to $21,000.McMurry-Heath is a major first in the industry. […]

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. AcceptRead More